<unk>  should not be given to these patients: *Hepatic dysfunction<unk>  should be used with caution in these higher risk categories: *Biliary tract disease *Renal dysfunction *Pregnant women *Obese patients
Gemfibrozil
Fenofibrate
Clofibrate
Ezetimibe
Lovastatin
Atorvastatin
Simvastatin
Fluvastatin